Note | |
| |
Entity | Philadelphia chromosome-positive (Ph+) leukemias |
Note | IRS1 was identified as a binding partner of BCR-ABL protein and found to be involved in the activation of the PI3K/Akt/mTOR and MAPK signaling pathway in the BCR-ABL network (Traina et al., 2003). In BCR-ABL positive leukemia cells, IRS1 silencing resulted in decreased cell proliferation and clonogenicity (Machado-Neto et al., 2011). In addition, IRS1 expression was found to be negatively correlated with survival in patients with Ph+ acute lymphosblastic leukemia, regardless of age and white blood cell count at diagnosis (Juric et al., 2007). |
| |
| |
Entity | Breast cancer |
Note | In breast cancer tumors, IRS1 has been described as constitutively activated and its expression has been correlated with poor differentiation and positive lymph node status (Chang et al., 2002; Lee et al., 1999; Koda et al., 2005). High levels of IRS1 were associated with lower disease-free survival and positively correlated with proliferation in estrogen receptor (ER) positive breast cancer tumors (Rocha et al., 1997). In ER positive breast cancer cells, IRS1 silencing promoted apoptosis and increased the sensibility to chemotherapy (Cesarone et al., 2006). |
| |
| |
Entity | Hepatocellular carcinoma |
Note | IRS1 was found overexpressed in 80% of hepatocellular carcinoma (HCC) when compared with adjacent HCC-free tissue (Cantarini et al., 2006). In vitro experiments provided evidence that IRS1 overexpression was able to promote malignant transformation of hepatocytes (Tanaka et al., 1997). |
| |
| |
Entity | Lung cancer |
Note | Han et al. reported a downregulation of IRS1 in non-small cell lung cancer (NSCLC) and suggested that loss of IRS1 might be an early event in NSCLC development (Han et al., 2006). |
| |
| |
Entity | Medulloblastoma |
Note | Abundant IRS1 expression was found in medulloblastoma cell lines and medulloblastoma biopsies. Nuclear translocation of IRS1 was observed in all cell lines and primary samples in the presence of the JC virus T antigen (Del Valle et al., 2002). |
| |
| |
Entity | Mesothelioma |
Note | Up-regulation of IRS1 was found in mesothelioma samples and may contribute to malignant pleural mesothelioma tumorigenesis by IGF1-induced cell proliferation (Hoang et al., 2004). |
| |
| |
Entity | Ovarian cancer |
Note | The majority of malignant epithelial ovarian tumors showed IRS1 overexpression when compared with normal ovarian tissue, suggesting a correlation between IRS1 expression and cancer phenotype. The same study suggested that IRS1 is an important growth-regulatory protein and may be a possible target in ovarian cancer (Ravikumar et al., 2007). |
| |
| |
Entity | Pancreatic cancer |
Note | IRS1 was highly expressed in 43% of pancreatic cancer samples when compared with normal pancreas samples (Bergmann et al., 1996). |
| |
| |
Entity | Prostate cancer |
Note | High expression of IRS1 was correlated with high expression of IGF1R in both benign and malignant prostate samples (Hellawell et al., 2002), but IRS1 expression did not differ among these samples. In prostate cancer cells, IRS1 silencing plus rapamycin treatment synergistically antagonized the activation of mTOR and induced tumor suppression in vivo, through inhibition of proliferation and induction of apoptosis (Oliveira et al., 2008). |
| |
| |
Entity | Endometrial cancer |
Note | IRS1 activation was significantly elevated in patients with endometrial cancer (EC) compared to those without EC and was associated with aggressive features. In addition, Wang et al. suggested that the inhibition of the IR/IRS1/PI3K/Akt pathway could be used as preventive and therapeutic strategies for EC (Wang et al., 2012). |
| |
| |
Entity | Colorectal cancer |
Note | Esposito et al. reported that IRS1 was found highly expressed in adenomas of familial adenomatous polyposis patients, relative to paired normal mucosa, and in metastasized colorectal tumors compared with primary colorectal cancer (CRC) and colonic epithelium (Esposito et al., 2012). The authors also related that IRS1 staining was associated with high expressions of Ki67, p53, and β-catenin, suggesting that IRS1 is modulated according to CRC differentiation and plays a role in CRC progression and metastasis (Esposito et al., 2012). |
| |
Increased expression of insulin receptor substrate-1 in human pancreatic cancer. |
Bergmann U, Funatomi H, Kornmann M, Beger HG, Korc M. |
Biochem Biophys Res Commun. 1996 Mar 27;220(3):886-90. |
PMID 8607861 |
|
Aspartyl-asparagyl beta hydroxylase over-expression in human hepatoma is linked to activation of insulin-like growth factor and notch signaling mechanisms. |
Cantarini MC, de la Monte SM, Pang M, Tong M, D'Errico A, Trevisani F, Wands JR. |
Hepatology. 2006 Aug;44(2):446-57. |
PMID 16871543 |
|
RNAi-mediated silencing of insulin receptor substrate 1 (IRS-1) enhances tamoxifen-induced cell death in MCF-7 breast cancer cells. |
Cesarone G, Garofalo C, Abrams MT, Igoucheva O, Alexeev V, Yoon K, Surmacz E, Wickstrom E. |
J Cell Biochem. 2006 May 15;98(2):440-50. |
PMID 16440325 |
|
Constitutive activation of insulin receptor substrate 1 is a frequent event in human tumors: therapeutic implications. |
Chang Q, Li Y, White MF, Fletcher JA, Xiao S. |
Cancer Res. 2002 Nov 1;62(21):6035-8. |
PMID 12414625 |
|
Oncogenic transformation by the signaling adaptor proteins insulin receptor substrate (IRS)-1 and IRS-2. |
Dearth RK, Cui X, Kim HJ, Hadsell DL, Lee AV. |
Cell Cycle. 2007 Mar 15;6(6):705-13. Epub 2007 Mar 20. (REVIEW) |
PMID 17374994 |
|
Insulin-like growth factor I receptor signaling system in JC virus T antigen-induced primitive neuroectodermal tumors--medulloblastomas. |
Del Valle L, Wang JY, Lassak A, Peruzzi F, Croul S, Khalili K, Reiss K. |
J Neurovirol. 2002 Dec;8 Suppl 2:138-47. (REVIEW) |
PMID 12491166 |
|
The insulin receptor substrate 1 (IRS1) in intestinal epithelial differentiation and in colorectal cancer. |
Esposito DL, Aru F, Lattanzio R, Morgano A, Abbondanza M, Malekzadeh R, Bishehsari F, Valanzano R, Russo A, Piantelli M, Moschetta A, Lotti LV, Mariani-Costantini R. |
PLoS One. 2012;7(4):e36190. doi: 10.1371/journal.pone.0036190. Epub 2012 Apr 27. |
PMID 22558377 |
|
Clinical significance of insulin receptor substrate-I down-regulation in non-small cell lung cancer. |
Han CH, Cho JY, Moon JT, Kim HJ, Kim SK, Shin DH, Chang J, Ahn CM, Kim SK, Chang YS. |
Oncol Rep. 2006 Dec;16(6):1205-10. |
PMID 17089038 |
|
Expression of the type 1 insulin-like growth factor receptor is up-regulated in primary prostate cancer and commonly persists in metastatic disease. |
Hellawell GO, Turner GD, Davies DR, Poulsom R, Brewster SF, Macaulay VM. |
Cancer Res. 2002 May 15;62(10):2942-50. |
PMID 12019176 |
|
Selective activation of insulin receptor substrate-1 and -2 in pleural mesothelioma cells: association with distinct malignant phenotypes. |
Hoang CD, Zhang X, Scott PD, Guillaume TJ, Maddaus MA, Yee D, Kratzke RA. |
Cancer Res. 2004 Oct 15;64(20):7479-85. |
PMID 15492273 |
|
Differential gene expression patterns and interaction networks in BCR-ABL-positive and -negative adult acute lymphoblastic leukemias. |
Juric D, Lacayo NJ, Ramsey MC, Racevskis J, Wiernik PH, Rowe JM, Goldstone AH, O'Dwyer PJ, Paietta E, Sikic BI. |
J Clin Oncol. 2007 Apr 10;25(11):1341-9. Epub 2007 Feb 20. |
PMID 17312329 |
|
Expression of insulin receptor substrate 1 in primary breast cancer and lymph node metastases. |
Koda M, Sulkowska M, Kanczuga-Koda L, Sulkowski S. |
J Clin Pathol. 2005 Jun;58(6):645-9. |
PMID 15917419 |
|
The role of insulin receptor substrate-1 gene (IRS1) in type 2 diabetes in Pima Indians. |
Kovacs P, Hanson RL, Lee YH, Yang X, Kobes S, Permana PA, Bogardus C, Baier LJ. |
Diabetes. 2003 Dec;52(12):3005-9. |
PMID 14633864 |
|
Enhancement of insulin-like growth factor signaling in human breast cancer: estrogen regulation of insulin receptor substrate-1 expression in vitro and in vivo. |
Lee AV, Jackson JG, Gooch JL, Hilsenbeck SG, Coronado-Heinsohn E, Osborne CK, Yee D. |
Mol Endocrinol. 1999 May;13(5):787-96. |
PMID 10319328 |
|
Knockdown of insulin receptor substrate 1 reduces proliferation and downregulates Akt/mTOR and MAPK pathways in K562 cells. |
Machado-Neto JA, Favaro P, Lazarini M, Costa FF, Olalla Saad ST, Traina F. |
Biochim Biophys Acta. 2011 Aug;1813(8):1404-11. doi: 10.1016/j.bbamcr.2011.04.002. Epub 2011 Apr 21. |
PMID 21569802 |
|
Expression and function of the insulin receptor substrate proteins in cancer. |
Mardilovich K, Pankratz SL, Shaw LM. |
Cell Commun Signal. 2009 Jun 17;7:14. doi: 10.1186/1478-811X-7-14. |
PMID 19534786 |
|
Antineoplastic effect of rapamycin is potentiated by inhibition of IRS-1 signaling in prostate cancer cells xenografts. |
Oliveira JC, Souza KK, Dias MM, Faria MC, Ropelle ER, Flores MB, Ueno M, Velloso LA, Saad ST, Saad MJ, Carvalheira JB. |
J Cancer Res Clin Oncol. 2008 Aug;134(8):833-9. doi: 10.1007/s00432-008-0359-5. Epub 2008 Feb 9. |
PMID 18264722 |
|
Insulin receptor substrate-1 is an important mediator of ovarian cancer cell growth suppression by all-trans retinoic acid. |
Ravikumar S, Perez-Liz G, Del Vale L, Soprano DR, Soprano KJ. |
Cancer Res. 2007 Oct 1;67(19):9266-75. |
PMID 17909034 |
|
Nuclear IRS-1 and cancer. |
Reiss K, Del Valle L, Lassak A, Trojanek J. |
J Cell Physiol. 2012 Aug;227(8):2992-3000. doi: 10.1002/jcp.24019. (REVIEW) |
PMID 22454254 |
|
Insulin-like growth factor binding protein-3 and insulin receptor substrate-1 in breast cancer: correlation with clinical parameters and disease-free survival. |
Rocha RL, Hilsenbeck SG, Jackson JG, VanDenBerg CL, Weng Cn, Lee AV, Yee D. |
Clin Cancer Res. 1997 Jan;3(1):103-9. |
PMID 9815544 |
|
Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. |
Sun XJ, Rothenberg P, Kahn CR, Backer JM, Araki E, Wilden PA, Cahill DA, Goldstein BJ, White MF. |
Nature. 1991 Jul 4;352(6330):73-7. |
PMID 1648180 |
|
Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. |
Tamemoto H, Kadowaki T, Tobe K, Yagi T, Sakura H, Hayakawa T, Terauchi Y, Ueki K, Kaburagi Y, Satoh S, et al. |
Nature. 1994 Nov 10;372(6502):182-6. |
PMID 7969452 |
|
Biological effects of human insulin receptor substrate-1 overexpression in hepatocytes. |
Tanaka S, Mohr L, Schmidt EV, Sugimachi K, Wands JR. |
Hepatology. 1997 Sep;26(3):598-604. |
PMID 9303488 |
|
BCR-ABL binds to IRS-1 and IRS-1 phosphorylation is inhibited by imatinib in K562 cells. |
Traina F, Carvalheira JB, Saad MJ, Costa FF, Saad ST. |
FEBS Lett. 2003 Jan 30;535(1-3):17-22. |
PMID 12560071 |
|
Mitogenic and anti-apoptotic effects of insulin in endometrial cancer are phosphatidylinositol 3-kinase/Akt dependent. |
Wang Y, Hua S, Tian W, Zhang L, Zhao J, Zhang H, Zhang W, Xue F. |
Gynecol Oncol. 2012 Jun;125(3):734-41. doi: 10.1016/j.ygyno.2012.03.012. Epub 2012 Mar 14. |
PMID 22426488 |
|